RxDoctor Payments Data

Ashley Vittum, APRN

Family · Concord, NHNPI 1699366906

Payments from drug & device makers

$1,302in general payments, 2019–2025

Across 61 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$443
  • Collegium Pharmaceutical, Inc.$172
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$161
  • Valinor Pharma, LLC$117
  • Teva Pharmaceuticals USA, Inc.$85
  • IBSA Pharma Inc.$66
  • plus $259 from 8 others

What the payments were for

  • Food & beverage$1,302100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,302 in reported general payments places this provider in the 85th percentile of 713 family providers in New Hampshire.

See all family providers in New Hampshire

Medicare billing

Part B allowed, 2024
$67,371
Medicare patients
95
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl55$57,228
OxycontinOxycodone Hcl80$38,393
Hysingla ErHydrocodone Bitartrate46$27,890
Xtampza ErOxycodone Myristate54$23,366
BelbucaBuprenorphine Hcl19$13,339
NucyntaTapentadol Hcl17$12,755
Buprenorphine43$10,709
Oxycodone Hcl472$10,464
ButransBuprenorphine14$7,680
ZubsolvBuprenorphine Hcl/Naloxone Hcl11$6,713
Morphine Sulfate ErMorphine Sulfate191$6,260
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen240$5,562
Buprenorphine Hcl98$4,174
Tramadol Hcl ErTramadol Hcl44$3,248
Lubiprostone17$2,534

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er, Belbuca, Nucynta$172$106,688145 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 713 family providers in New Hampshire.

Other family in Concord

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →